Inhibikase Therapeutics Stock Forecast - Market Facilitation Index
| IKT Stock | USD 3.37 0.13 4.01% |
Inhibikase Stock Forecast is based on your current time horizon.
Inhibikase |
| Check Inhibikase Therapeutics Volatility | Backtest Inhibikase Therapeutics | Information Ratio |
Inhibikase Therapeutics Trading Date Momentum
| On December 13 2024 Inhibikase Therapeutics was traded for 3.37 at the closing time. Highest Inhibikase Therapeutics's price during the trading hours was 3.37 and the lowest price during the day was 3.24 . There was no trading activity during the period 0.0. Lack of trading volume on the 13th of December 2024 did not cause price change. The trading delta at closing time to current price is 3.71% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
| Compare Inhibikase Therapeutics to competition |
Other Forecasting Options for Inhibikase Therapeutics
For every potential investor in Inhibikase, whether a beginner or expert, Inhibikase Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inhibikase Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inhibikase. Basic forecasting techniques help filter out the noise by identifying Inhibikase Therapeutics' price trends.Inhibikase Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inhibikase Therapeutics stock to make a market-neutral strategy. Peer analysis of Inhibikase Therapeutics could also be used in its relative valuation, which is a method of valuing Inhibikase Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Inhibikase Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Inhibikase Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Inhibikase Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Inhibikase Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Inhibikase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibikase Therapeutics shares will generate the highest return on investment. By undertsting and applying Inhibikase Therapeutics stock market strength indicators, traders can identify Inhibikase Therapeutics entry and exit signals to maximize returns.
Inhibikase Therapeutics Risk Indicators
The analysis of Inhibikase Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inhibikase Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inhibikase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.09 | |||
| Semi Deviation | 4.5 | |||
| Standard Deviation | 7.12 | |||
| Variance | 50.72 | |||
| Downside Variance | 31.52 | |||
| Semi Variance | 20.28 | |||
| Expected Short fall | (6.44) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Inhibikase Stock Analysis
When running Inhibikase Therapeutics' price analysis, check to measure Inhibikase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase Therapeutics is operating at the current time. Most of Inhibikase Therapeutics' value examination focuses on studying past and present price action to predict the probability of Inhibikase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase Therapeutics' price. Additionally, you may evaluate how the addition of Inhibikase Therapeutics to your portfolios can decrease your overall portfolio volatility.